Breaking News, Collaborations & Alliances

Nona Biosciences, Boostimmune Enter ADC Alliance

To leverage Nona's Harbour Mice H2L2 platform to accelerate development of Antibody-Drug Conjugates against novel targets.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd. committed to technology innovations and providing a total solution from “Idea to IND” (“I to ITM”), has entered into a collaboration agreement with Boostimmune, a biotech company developing next-generation anti-cancer therapies via modulating immune systems. The collaboration aims to leverage Nona’s Harbour Mice H2L2 (two light and two heavy chain) platform to accelerate the development of Antibody-Dru...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters